Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Trends in Cancer Research   Volumes    Volume 15 
Leveraging immunogenic cell death to potentiate immune checkpoint therapy in cancer
Jessica K. Lin, Shiaw-Yih Lin
Pages: 33 - 38
Number of pages: 6
Trends in Cancer Research
Volume 15 

Copyright © 2020 Research Trends. All rights reserved

Immune checkpoint therapy (ICT) is exceptionally clinically attractive because it offers not only durable responses, but also better quality of life than many other treatments. In addition to neoantigens that are required for tumors to be recognized and targeted by cytotoxic T cells after ICT, the tumor microenvironment has been considered as a major determinant for the tumor responsiveness to ICT. In general, tumors that are not inflamed and do not elicit a response from the immune system do not respond to ICT. Therefore, creating an immunogenic tumor microenvironment is critical for achieving optimal ICT response. Immunogenic cell death (ICD) is a unique form of stress-induced cell death that drives inflammatory response in tumors and culminates with adaptive immunity. In this mini-review, we will first briefly introduce the mechanistic and functional features of ICD. We will then summarize the published studies in regard to how we can apply ICD-inducing strategies to enhance the effectiveness of ICT for cancer treatment.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms